Statewide

Virgin Islands Fire & Emergency Medical Services

Name: Virgin Islands Fire & Emergency Medical Services EMS protocol doses
Creator: ProtoQuiz
License: https://protoquiz.com/census/data-license/

May be outdated127 dose entries28 drugs1 documentVIeffective 2024-06-01100% machine-parsed of 127

The current listed document is more than 24 months old and may be outdated.

Drugs and doses28

A–C Acetaminophen, Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Calcium Chloride7

Acetaminophen

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	650 mg	PO	not captured	standing	pages 87, 89, 174
Mild to moderate pain	peds	160 mg	PO	not captured	standing	pages 87, 89, 174

Adenosine

Indication	Population	Dose	Route	Repeat	Standing	Source
Narrow-complex tachycardia	adult	6 mg	IV	not captured	standing	page 175
Narrow-complex tachycardia	peds	0.1 mg/kg	IV	not captured	standing	page 175

Albuterol

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	2 puff	MDI	not captured	standing	pages 112, 113, 166, 176
Asthma / bronchospasm	adult	2.5 mg	NEB	not captured	standing	pages 112, 113, 166, 176
Asthma / bronchospasm	peds	1.25 mg	NEB	not captured	standing	pages 112, 113, 166, 176
Asthma / bronchospasm	peds	2 puff	MDI	not captured	standing	pages 112, 113, 166, 176
Hyperkalemia	peds	2.5 mg	NEB	not captured	standing	pages 83, 84, 176, 177

Amiodarone

Indication	Population	Dose	Route	Repeat	Standing	Source
Atrial fibrillation with RVR	adult	150 mg	IV/IO	not captured	standing	pages 39, 179
Atrial fibrillation with RVR	adult	150 mg	IV/IO	not captured	standing	pages 39, 179
Wide-complex tachycardia	adult	300 mg	IV/IO	not captured	standing	pages 44, 47, 178, 179
Wide-complex tachycardia	peds	5 mg/kg	IV/IO	not captured	standing	pages 44, 47, 178, 179
VF / pulseless VT	adult	300 mg	IV/IO	not captured	standing	pages 44, 47, 178, 179
VF / pulseless VT	peds	5 mg/kg	IV/IO	not captured	standing	pages 44, 47, 178, 179

Aspirin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	324 mg	PO	not captured	standing	pages 62, 167, 180

Atropine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	0.5–1 mg	IV	not captured	standing	pages 37, 38, 181, 182
Bradycardia	peds	0.02 mg/kg	IV	not captured	standing	pages 37, 38, 181, 182
Nerve agent exposure	adult	6 mg	IM	not captured	standing	pages 274, 275
Organophosphate poisoning	adult	2–4 mg	IV/IM	not captured	standing	page 182
Organophosphate poisoning	peds	0.02 mg/kg	IV/IM	not captured	standing	page 182

Calcium Chloride

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	0.5–1 g	IV/IO	not captured	standing	pages 129, 131, 183
Beta-blocker / calcium-channel-blocker overdose	peds	20 mg/kg	IV/IO	not captured	standing	pages 129, 131, 183
Hyperkalemia	adult	0.5–1 g	IV/IO	not captured	standing	pages 43, 83, 84, 183
Hyperkalemia	peds	20 mg/kg	IV/IO	not captured	standing	pages 43, 83, 84, 183
Other	adult	0.5–1 g	IV/IO	not captured	standing	page 183
Other	adult	500 mg	IV/IO	not captured	standing	pages 39, 183
Other	adult	500 mg	IV/IO	not captured	standing	page 183
Other	peds	20 mg/kg	IV/IO	not captured	standing	page 183

D–F Dextrose, Diazepam, Diphenhydramine, Dopamine, Epinephrine, Fentanyl6

Dextrose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	25 g	IV/IO	not captured	standing	pages 81, 82, 184, 185
Hypoglycemia	peds	2 mL/kg	IV/IO	not captured	standing	pages 81, 82, 184, 185

Diazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	10 mg	IM	not captured	standing	pages 274, 275
Nerve agent exposure	peds	0.1 mg/kg	IM	not captured	standing	pages 274, 275
Seizure	adult	2.5–10 mg	IV/IO	not captured	standing	pages 91, 92, 186
Seizure	peds	0.1 mg/kg	IV/IO	not captured	standing	pages 91, 92, 186
Seizure	peds	0.2 mg/kg	PR	not captured	standing	pages 92, 186

Diphenhydramine

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	25 mg	IV/IM	not captured	standing	pages 73, 74, 189
Allergic reaction	peds	1 mg/kg	IV/IM	not captured	standing	pages 73, 74, 189
Anaphylaxis	adult	50 mg	IV/IM	not captured	standing	pages 77, 78, 189
Anaphylaxis	peds	1 mg/kg	IV/IM	not captured	standing	pages 77, 78, 189
Dystonic reaction	adult	25–50 mg	IV/IM	not captured	standing	pages 70, 72, 189, 199
Dystonic reaction	peds	1 mg/kg	IV/IM	not captured	standing	pages 70, 72, 189, 199

Dopamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	2–20 mcg/kg	IV/IO	not captured	standing	pages 190, 191
Anaphylaxis	peds	2–20 mcg/kg	IV/IO	not captured	standing	pages 190, 191
Cardiogenic shock	adult	2–20 mcg/kg	IV/IO	not captured	standing	pages 190, 191
Cardiogenic shock	peds	2–20 mcg/kg	IV/IO	not captured	standing	pages 190, 191
Sepsis	adult	2–20 mcg/kg	IV/IO	not captured	standing	pages 190, 191
Sepsis	peds	2–20 mcg/kg	IV/IO	not captured	standing	pages 190, 191
Trauma / hemorrhage	adult	2–20 mcg/kg	IV/IO	not captured	standing	pages 190, 191
Trauma / hemorrhage	peds	2–20 mcg/kg	IV/IO	not captured	standing	pages 190, 191

Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	0.3 mg	IM	not captured	standing	pages 73, 77, 78, 168, 169
Anaphylaxis	peds	0.15 mg	IM	not captured	standing	pages 73, 77, 78, 168, 169
Bradycardia	adult	2–10 mcg	IV/IO	not captured	standing	pages 37, 38, 193
Bradycardia	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 37, 38, 193
Cardiac arrest	adult	1 mg	IV/IO	not captured	standing	pages 43, 44, 47, 193
Cardiac arrest	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 43, 44, 47, 193
Croup	peds	2.5 mL	NEB	not captured	standing	page 119

Fentanyl

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	1 mcg/kg	IV/IO/IM/IN	not captured	standing	pages 88, 90, 196, 197
Mild to moderate pain	peds	1 mcg/kg	IV/IO/IM/IN	not captured	standing	pages 88, 90, 196, 197

G–L Glucagon, Haloperidol, Ipratropium, Ketorolac, Lidocaine5

Glucagon

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	1 mg	IV	not captured	standing	pages 130, 132, 198
Beta-blocker / calcium-channel-blocker overdose	peds	0.5 mg	IV	not captured	standing	pages 130, 132, 198
Hypoglycemia	adult	1 mg	IM/IN	not captured	standing	pages 81, 82, 184, 198
Hypoglycemia	peds	0.5 mg	IM/IN	not captured	standing	pages 81, 82, 184, 198

Haloperidol

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	2.5–5 mg	IM	not captured	standing	page 199
Agitation	peds	2.5–5 mg	IM	not captured	standing	page 199

Ipratropium

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	0.5 mg	NEB	not captured	standing	pages 73, 75, 200
Allergic reaction	peds	0.25 mg	NEB	not captured	standing	pages 73, 75, 200
Asthma / bronchospasm	adult	500 mcg	NEB	not captured	standing	pages 112, 113, 200
Asthma / bronchospasm	peds	250 mcg	NEB	not captured	standing	pages 112, 113, 200
CHF / pulmonary edema	adult	0.5 mg	NEB	not captured	standing	pages 116, 118, 200
CHF / pulmonary edema	peds	0.5 mg	NEB	not captured	standing	pages 116, 118, 200
COPD	adult	500 mcg	NEB	not captured	standing	pages 112, 200

Ketorolac

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	15 mg	IV/IM	not captured	standing	pages 88, 90, 201, 202
Mild to moderate pain	peds	0.5 mg/kg	IV/IM	not captured	standing	pages 88, 90, 201, 202

Lidocaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2 mL	IN	not captured	standing	page 206
Mild to moderate pain	adult	20–40 mg	IO	not captured	standing	pages 206, 250
Mild to moderate pain	peds	10 mg	IO	not captured	standing	pages 206, 250

M–O Magnesium Sulfate, Midazolam, Morphine, Naloxone, Nerve Agent Antidote Kit, Nitroglycerin, Ondansetron, Oral Glucose8

Magnesium Sulfate

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1–2 g	IV/IO	not captured	standing	page 208
Other	adult	4 g	IV/IO	not captured	standing	page 208
Other	peds	4 g	IV/IO	not captured	standing	page 208
Other	peds	50 mg/kg	IV/IO	not captured	standing	page 208
VF / pulseless VT	adult	1–2 g	IV/IO	not captured	standing	page 208
VF / pulseless VT	adult	1–2 g	IV/IO	not captured	standing	page 208
VF / pulseless VT	peds	25 mg/kg	IV/IO	not captured	standing	page 208

Midazolam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	5 mg	IV/IM	not captured	standing	pages 210, 211
Agitation	peds	0.1 mg/kg	IV/IM	not captured	standing	pages 210, 211
Other	adult	0.1 mg/kg	IV/IO	not captured	standing	page 211
Other	adult	0.1 mg/kg	IV/IO	not captured	standing	page 135
Other	peds	0.05 mg/kg	IV/IO	not captured	standing	page 211
Other	peds	0.1 mg/kg	IV/IO	not captured	standing	page 135
Procedural sedation	adult	0.1 mg/kg	IV/IO	not captured	standing	page 246
Procedural sedation	peds	0.1 mg/kg	IV/IO	not captured	standing	page 246
Seizure	adult	0.1 mg/kg	IV/IO	not captured	standing	pages 210, 211
Seizure	adult	5 mg	IM/IN	not captured	standing	pages 210, 211
Seizure	peds	0.1 mg/kg	IV/IO	not captured	standing	pages 210, 211
Seizure	peds	0.2 mg/kg	IM/IN	not captured	standing	pages 210, 211

Morphine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	peds	0.1 mg/kg	IV/IO/IM	not captured	standing	page 213
Severe pain	adult	0.1 mg/kg	IV/IM	not captured	standing	page 213
Severe pain	peds	0.1 mg/kg	IV/IM	not captured	standing	page 213

Naloxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Opioid overdose	adult	0.4 mg	IV/IO/IM	not captured	standing	pages 129, 131, 214
Opioid overdose	adult	2 mg	IN	not captured	standing	pages 129, 131, 170, 214, 269, 270
Opioid overdose	peds	0.1 mg/kg	IV/IO/IM	not captured	standing	pages 129, 131, 214
Opioid overdose	peds	2 mg	IN	not captured	standing	pages 129, 131, 170, 214, 269, 270

Nerve Agent Antidote Kit

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	6 mg	IM	not captured	standing	pages 274, 275
Nerve agent exposure	peds	6 mg	IM	not captured	standing	pages 274, 275

Nitroglycerin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	0.4 mg	SL	not captured	standing	pages 62, 171, 215
CHF / pulmonary edema	adult	0.4 mg	SL	not captured	standing	pages 116, 216

Ondansetron

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	4–8 mg	IV	not captured	standing	page 218
Nausea / vomiting	adult	4–8 mg	IM	not captured	standing	page 218
Nausea / vomiting	adult	8 mg	PO	not captured	standing	page 218
Nausea / vomiting	peds	0.1 mg/kg	IV	not captured	standing	page 218
Nausea / vomiting	peds	0.1 mg/kg	IM	not captured	standing	page 218
Nausea / vomiting	peds	8 mg	PO	not captured	standing	page 218

Oral Glucose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	10–15 g	PO	not captured	standing	pages 81, 82, 172
Hypoglycemia	peds	10–15 g	PO	not captured	standing	pages 81, 82, 172

S–Z Sodium Bicarbonate, Tranexamic Acid2

Sodium Bicarbonate

Indication	Population	Dose	Route	Repeat	Standing	Source
Crush injury	adult	50 mEq	IV/IO	not captured	standing	pages 220, 221
Crush injury	peds	1 mEq/kg	IV/IO	not captured	standing	pages 220, 221
Hyperkalemia	adult	50 mEq	IV/IO	not captured	standing	pages 220, 221
Hyperkalemia	peds	1 mEq/kg	IV/IO	not captured	standing	pages 220, 221
Other	adult	1 mEq/kg	IV/IO	not captured	standing	pages 220, 221
Other	adult	1 mEq/kg	IV/IO	not captured	standing	pages 220, 221
Other	peds	1 mEq/kg	IV/IO	not captured	standing	pages 220, 221
Other	peds	1 mEq/kg	IV/IO	not captured	standing	pages 220, 221

Tranexamic Acid

Indication	Population	Dose	Route	Repeat	Standing	Source
Obstetric hemorrhage	adult	1 g	IV/IO	not captured	standing	page 222
Obstetric hemorrhage	peds	1 g	IV/IO	not captured	standing	page 222
Trauma / hemorrhage	adult	1 g	IV/IO	not captured	standing	page 222
Trauma / hemorrhage	peds	1 g	IV/IO	not captured	standing	page 222

Cite this

Virgin Islands Fire & Emergency Medical Services, United States EMS Protocol Census. 127 dose entries, effective 2024-06-01.

https://protoquiz.com/census/agencies/virgin-islands-fire-emergency-medical-services/

Outdated or wrong? Fix or remove it All VI agencies Methodology Data license Study these protocols in the app

The census is free and not for sale. Only public agencies are named.